Table 3.
Summary of previous renal biopsy studies in People Living With HIV. “not listed” means that the study did not report on the specific variable, “nil” means there was no cases.—Diabetes Mellitus (DM), Hypertension (HTN), Hepatitis B core positive (Hep B), Hepatitis C antibody positive (Hep C), Tubulointerstitial nephritis (TIN), membranoproliferative glomerulonephritis (MPGN), Human immunodeficiency virus associated Nephritis (HIVAN), diabetic nephropathy (DN), Haemolytic-ureamic syndrome (HUS), Immune-complex disease (ICD), Acute Interstitial Nephritis (AIN) and Immunoglobulin A nephropathy (IgA)
| Paper | Year | Country | Number of patients | Mean Age | Serum Creatinine | DM | HTN | Hep B | Hep C | Most Common Diagnosis | TIN | HIVAN | ICD | DN | HTN |
| This study | 2021 | Australia | 19 | 47.9 | 1.49 mg/dL | 4 (21.1%) | 14 (73.7%) | 7 (36.8%) | 3 (15.8%) | TIN 5 (24%) | 4 (21%) | nil | IgA 3 (14%) | 2 (8%) | 4 (17%) |
| Praditopornsilpa [14] | 1999 | Thailand | 26 | 31 | 2.36 mg/dL | excluded | nil | exlcuded | exlcuded | MPGN 17 (65%) | 17 (65%) | nil | IgA 2 (7.6%) | nil | nil |
| Berliner [12] | 2004 | United states | 152 | 42.6 | 4.1 mg/dL | 26 (17.1%) | 92 (62%) | 12 (8.4%) | 86 (59.3%) | HIVAN 53 (34.9%) | 12 (7.9%) | 53 (34.9%) | IgA 3 (2%) | 8 (5.3%) | 5 (3.3%) |
| Singh [15] | 2019 | India | 10 | 34.1 | 1.84 mg/dL | not listed | not listed | not listed | not listed | MPGN 5 (50%) | 2 (20%) | 2 (20%) | nil | 1 (10%) | nil |
| Hara [16] | 2018 | Japan | 10 | 54 | 1.56 mg/dL | 4 (40%) | 5 (50%) | 2 (20%) | 2 (20%) | DN 3 (33%) | 2 (20%) | nil | nil | 3 (33%) | nil |
| Vermeulen [13] | 2019 | South Africa | 1848 | 33.5 | 3.57 mg/dL | not listed | not listed | 83 (4.5%) | 28 (1.5%) | HIVAN 604 (32.7%) | 70 (2.8%) | 604 (32.7%) | ICD 218 (11.8%) | 81 (4.4%) | 55 (3%) |
| Williams [17] | 1998 | England | 17 | 37.8 | not listed | not listed | not listed | 4 (23%) | not listed | HIVAN 7 (41%) | 1 (5.8%) | 7 (41%) | IgA 1 (5.8%) | nil | nil |
| Peraldi [18] | 1999 | France | 60 | 35.1 | 5.43 mg/dL | not listed | 11 (18.3%) | 1 (1.6%) | 1 (1.6%) | HUS 32 (35%) | 18 ( 19.5%) | 14 (15.2%) | ICD 2 (2.17%) | nil | nil |
| Nebuloni [19] | 2009 | Italy | 73 | not listed | not listed | not listed | not listed | not listed | not listed | ICD 40 (54.7%) | nil | 9 (12.3%) | ICD 40 (54.7%) | 4 (5.4%) | nil |
| Schmid [20] | 2007 | Switzerland | 30 | 35 | not listed | not listed | not listed | not listed | 2 (6.6%) | ICD 13 (43%) | 6 (20%) | 2 (6.6%) | ICD 13 (43%) | 1 (3.3%) | 1 (3.3%) |